Cargando…

Probing pathomechanisms of mucolipidosis II in fish

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Company of Biologists Limited 2012
Materias:	In this Issue
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291625/

Ejemplares similares

Hip Morphology in Mucolipidosis Type II
por: Ammer, Luise Sophie, et al.
Publicado: (2020)

Neurologic Abnormalities in Mouse Models of the Lysosomal Storage Disorders Mucolipidosis II and Mucolipidosis III γ
por: Idol, Rachel A., et al.
Publicado: (2014)

Correction: Neurologic Abnormalities in Mouse Models of the Lysosomal Storage Disorders Mucolipidosis II and Mucolipidosis III γ
Publicado: (2014)

Case Report: Mucolipidosis II and III Alpha/Beta Caused by Pathogenic Variants in the GNPTAB Gene (Mucolipidosis)
por: Mao, Shao-Jia, et al.
Publicado: (2022)

Mucolipidosis II: first report from Saudi Arabia
por: Alfadhel, Majid, et al.
Publicado: (2013)

New targets for old diseases: lessons from mucolipidosis type II
por: Settembre, Carmine, et al.
Publicado: (2013)

Elevated Bone Turnover in an Infantile Patient with Mucolipidosis II; No Association with Hyperparathyroidism
por: Otomo, Takanobu, et al.
Publicado: (2011)

Mucolipidosis Type II Secondary to GNPTAB Gene Deletion from India
por: Gowda, Vykuntaraju K., et al.
Publicado: (2017)

The Dictyostelium Model for Mucolipidosis Type IV
por: Allan, Claire Y., et al.
Publicado: (2022)

Decreased bone formation and increased osteoclastogenesis cause bone loss in mucolipidosis II
por: Kollmann, Katrin, et al.
Publicado: (2013)

Pitfalls in the prenatal diagnosis of mucolipidosis II alpha/beta: A case report
por: Alegra, Taciane, et al.
Publicado: (2014)

Characterization of mesenchymal stem cells in mucolipidosis type II (I-cell disease)
por: KÖSE, Sevil, et al.
Publicado: (2019)

Is hematopoietic stem cell transplantation a therapeutic option for mucolipidosis type II?
por: Ammer, Luise Sophie, et al.
Publicado: (2021)

Quaternary diagnostics scheme for mucolipidosis II and detection of novel mutation in GNPTAB gene
por: Essawi, Mona L., et al.
Publicado: (2021)

Orofacial abnormalities in mucopolysaccharidosis and mucolipidosis type II and III: A systematic review
por: de Bode, Chiel J., et al.
Publicado: (2022)

Autophagic dysfunction in mucolipidosis type IV patients
por: Vergarajauregui, Silvia, et al.
Publicado: (2008)

Vacuolization of mucolipidosis type II mouse exocrine gland cells represents accumulation of autolysosomes
por: Boonen, Marielle, et al.
Publicado: (2011)

A GNPTAB nonsense variant is associated with feline mucolipidosis II (I-cell disease)
por: Wang, Ping, et al.
Publicado: (2018)

Secondary Hyperparathyroidism in Children with Mucolipidosis Type II (I-Cell Disease): Irish Experience
por: Boruah, Ritma, et al.
Publicado: (2022)

Can rodent models elucidate the pathomechanisms of genetic epilepsy?
por: Okada, Motohiro
Publicado: (2021)

In vitro substrate reduction, chaperone and immunomodulation treatments reduce heparan sulfate in mucolipidosis III human fibroblasts
por: Sperb-Ludwig, Fernanda, et al.
Publicado: (2023)

Mucolipidosis type III, a series of adult patients
por: Oussoren, Esmee, et al.
Publicado: (2018)

Unique molecular signature in mucolipidosis type IV microglia
por: Cougnoux, Antony, et al.
Publicado: (2019)

Diagnosis of Mucopolysaccharidoses and Mucolipidosis by Assaying Multiplex Enzymes and Glycosaminoglycans
por: Arunkumar, Nivethitha, et al.
Publicado: (2021)

Excessive activity of cathepsin K is associated with cartilage defects in a zebrafish model of mucolipidosis II
por: Petrey, Aaron C., et al.
Publicado: (2012)

A case of mucolipidosis II presenting with prenatal skeletal dysplasia and severe secondary hyperparathyroidism at birth
por: Heo, Ju Sun, et al.
Publicado: (2012)

A Novel Mouse Model of a Patient Mucolipidosis II Mutation Recapitulates Disease Pathology
por: Paton, Leigh, et al.
Publicado: (2014)

Clinical, biochemical and molecular characterization of Korean patients with mucolipidosis II/III and successful prenatal diagnosis
por: Yang, Mina, et al.
Publicado: (2017)

Placental pathology in an unsuspected case of mucolipidosis type II with secondary hyperparathyroidism in a premature infant
por: Wongkittichote, Parith, et al.
Publicado: (2021)

Multiplex tandem mass spectrometry enzymatic activity assay for the screening and diagnosis of Mucolipidosis type II and III
por: Hong, Xinying, et al.
Publicado: (2023)

The first genetically confirmed Japanese patient with mucolipidosis type IV
por: Saijo, Harumi, et al.
Publicado: (2016)

Cross-sectional Observations on the Natural History of Mucolipidosis Type IV
por: Misko, Albert L., et al.
Publicado: (2022)

Mutation Analysis of 16 Mucolipidosis II and III Alpha/Beta Chinese Children Revealed Genotype-Phenotype Correlations
por: Liu, Shuang, et al.
Publicado: (2016)

Transgenic inhibition of interleukin-6 trans-signaling does not prevent skeletal pathologies in mucolipidosis type II mice
por: Westermann, Lena Marie, et al.
Publicado: (2021)

Outcomes after HSCT for mucolipidosis II (I-cell disease) caused by novel compound heterozygous GNPTAB mutations
por: He, Si-jia, et al.
Publicado: (2023)

Humoral immune response in adult Brazilian patients with Mucolipidosis III gamma
por: Sperb-Ludwig, Fernanda, et al.
Publicado: (2019)

Peripheral Inflammatory Cytokine Signature Mirrors Motor Deficits in Mucolipidosis IV
por: Misko, Albert L., et al.
Publicado: (2022)

Pathomechanisms of Paraneoplastic Myasthenia Gravis
por: Ströbel, Philipp, et al.
Publicado: (2003)

Overview on the pathomechanisms of allergic rhinitis
por: Pawankar, Ruby, et al.
Publicado: (2011)

Microscopic enteritis and pathomechanism of malabsorption
por: Rostami, Kamran, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ioc438rlimg4dfv4ai51sfev7f